While T cell-based immunotherapies are steadily improving, there are still many patients who progress, despite T cell-infiltrated tumors. Emerging evidence suggests that T cells themselves may provoke immune escape of cancer cells. Here, we describe a well-controlled co-culture system for studying the dynamic T cell - cancer cell interplay, using human melanoma as a model. We explain starting material, controls, and culture parameters to establish reproducible and comparable cultures with highly heterogeneous tumor cells. Low passage melanoma cell lines and melanoma-specific CD8+ T cell clones generated from patient blood were cultured together for up to 3 days. Living melanoma cells were isolated from the co-culture system by fluorescence-...
A major limiting factor in the success of immunotherapy is tumor infiltration by CD8(+) T cells, a p...
Recently, T cell based immunotherapies have moved to the forefront of cancer immunotherapy with the ...
AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. An...
While T cell-based immunotherapies are steadily improving, there are still many patients who progres...
Immunotherapies against cancer continue to improve, but many cancers show primary or secondary resis...
Intratumoral immune cells are crucial for tumor control and antitumor responses during immunotherapy...
Adoptive cell transfer (ACT) of genetically engineered T cells expressing cancer-specific T-cell rec...
SUMMARYAs a result of evolution, humans are equipped with an intricate but very effective immune sys...
Completed under a Cotutelle arrangement between the University of Melbourne and Bonn University© 20...
Although mutations drive cancer, it is less clear to what extent genetic defects control immune mech...
Objectives: Melanoma is a type of skin cancer derived from melanocytes, with a high mortality rate a...
T-cell vaccination may prevent or treat cancer and infectious diseases, but further progress is requ...
Natural killer (NK) receptor signaling can lead to reduced cytotoxicity by NK cells and cytolytic T ...
It is now widely accepted that T lymphocytes can participate in the elimination of tumor cells. T ce...
The development of immunotherapeutic approaches for the treatment of melanoma requires a better unde...
A major limiting factor in the success of immunotherapy is tumor infiltration by CD8(+) T cells, a p...
Recently, T cell based immunotherapies have moved to the forefront of cancer immunotherapy with the ...
AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. An...
While T cell-based immunotherapies are steadily improving, there are still many patients who progres...
Immunotherapies against cancer continue to improve, but many cancers show primary or secondary resis...
Intratumoral immune cells are crucial for tumor control and antitumor responses during immunotherapy...
Adoptive cell transfer (ACT) of genetically engineered T cells expressing cancer-specific T-cell rec...
SUMMARYAs a result of evolution, humans are equipped with an intricate but very effective immune sys...
Completed under a Cotutelle arrangement between the University of Melbourne and Bonn University© 20...
Although mutations drive cancer, it is less clear to what extent genetic defects control immune mech...
Objectives: Melanoma is a type of skin cancer derived from melanocytes, with a high mortality rate a...
T-cell vaccination may prevent or treat cancer and infectious diseases, but further progress is requ...
Natural killer (NK) receptor signaling can lead to reduced cytotoxicity by NK cells and cytolytic T ...
It is now widely accepted that T lymphocytes can participate in the elimination of tumor cells. T ce...
The development of immunotherapeutic approaches for the treatment of melanoma requires a better unde...
A major limiting factor in the success of immunotherapy is tumor infiltration by CD8(+) T cells, a p...
Recently, T cell based immunotherapies have moved to the forefront of cancer immunotherapy with the ...
AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. An...